2-32224523-C-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_001199138.2(NLRC4):c.3025G>T(p.Asp1009Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,613,278 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1009G) has been classified as Uncertain significance.
Frequency
Consequence
NM_001199138.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NLRC4 | NM_001199138.2 | c.3025G>T | p.Asp1009Tyr | missense_variant | 9/9 | ENST00000402280.6 | |
NLRC4 | NM_001199139.1 | c.3025G>T | p.Asp1009Tyr | missense_variant | 9/9 | ||
NLRC4 | NM_021209.4 | c.3025G>T | p.Asp1009Tyr | missense_variant | 9/9 | ||
NLRC4 | NM_001302504.1 | c.1030G>T | p.Asp344Tyr | missense_variant | 8/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NLRC4 | ENST00000402280.6 | c.3025G>T | p.Asp1009Tyr | missense_variant | 9/9 | 1 | NM_001199138.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152108Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000719 AC: 105AN: 1461170Hom.: 0 Cov.: 30 AF XY: 0.0000798 AC XY: 58AN XY: 726890
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74300
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2023 | The c.3025G>T (p.D1009Y) alteration is located in exon 9 (coding exon 8) of the NLRC4 gene. This alteration results from a G to T substitution at nucleotide position 3025, causing the aspartic acid (D) at amino acid position 1009 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Periodic fever-infantile enterocolitis-autoinflammatory syndrome;C4015276:Familial cold autoinflammatory syndrome 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 15, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NLRC4 protein function. ClinVar contains an entry for this variant (Variation ID: 1481766). This variant has not been reported in the literature in individuals affected with NLRC4-related conditions. This variant is present in population databases (rs374967155, gnomAD 0.002%). This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 1009 of the NLRC4 protein (p.Asp1009Tyr). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at